| Title |
Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa
|
|---|---|
| Published in |
PLOS ONE, March 2012
|
| DOI | 10.1371/journal.pone.0032144 |
| Pubmed ID | |
| Authors |
Julie H. Levison, Catherine Orrell, Sébastien Gallien, Daniel R. Kuritzkes, Naishin Fu, Elena Losina, Kenneth A. Freedberg, Robin Wood |
| Abstract |
We investigated the prevalence of wild-type virus (no major drug resistance) and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large HIV treatment program in South Africa. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 50% |
| South Africa | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 2% |
| Mozambique | 1 | <1% |
| Tanzania, United Republic of | 1 | <1% |
| Kenya | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 114 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 19% |
| Student > Ph. D. Student | 18 | 15% |
| Researcher | 16 | 13% |
| Student > Doctoral Student | 9 | 8% |
| Student > Postgraduate | 8 | 7% |
| Other | 23 | 19% |
| Unknown | 23 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 42% |
| Social Sciences | 10 | 8% |
| Immunology and Microbiology | 8 | 7% |
| Nursing and Health Professions | 8 | 7% |
| Agricultural and Biological Sciences | 5 | 4% |
| Other | 13 | 11% |
| Unknown | 26 | 22% |